Olga Nakasolya
Overview
Explore the profile of Olga Nakasolya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cox S, Erisa K, Kitonsa P, Nalutaaya A, Nantale M, Kayondo F, et al.
Ann Am Thorac Soc
. 2024 Jan;
21(6):875-883.
PMID: 38259069
C-reactive protein (CRP) has demonstrated utility as a point-of-care triage test for tuberculosis (TB) in clinical settings, particularly among people with human immunodeficiency virus (HIV), but its performance for general-population...
2.
Sung J, Nantale M, Nalutaaya A, Biche P, Mukiibi J, Kamoga C, et al.
Clin Infect Dis
. 2023 Oct;
78(3):723-729.
PMID: 37787077
Background: "Trace" results on Xpert MTB/RIF Ultra ("Ultra"; Cepheid) -a molecular diagnostic test for tuberculosis (TB)-are often interpreted as an indication for TB treatment, but may also represent detection of...
3.
Robsky K, Isooba D, Nakasolya O, Mukiibi J, Nalutaaya A, Kitonsa P, et al.
PLoS One
. 2021 May;
16(5):e0251806.
PMID: 33989343
Background: International and internal migration are recognized risk factors for tuberculosis (TB). Geographic mobility, including travel for work, education, or personal reasons, may also play a role in TB transmission,...
4.
Kitonsa P, Nalutaaya A, Mukiibi J, Nakasolya O, Isooba D, Kamoga C, et al.
PLoS One
. 2020 Dec;
15(12):e0243542.
PMID: 33306710
Background: When evaluating symptomatic patients for tuberculosis (TB) without access to same-day diagnostic test results, clinicians often make empiric decisions about starting treatment. The number of TB symptoms and/or underweight...
5.
Kendall E, Kitonsa P, Nalutaaya A, Erisa K, Mukiibi J, Nakasolya O, et al.
Clin Infect Dis
. 2020 Dec;
72(12):e1035-e1043.
PMID: 33283227
Background: New, sensitive diagnostic tests facilitate identification and investigation of milder forms of tuberculosis (TB) disease. We used community-based TB testing with the Xpert MTB/RIF Ultra assay ("Ultra") to characterize...
6.
Robsky K, Kitonsa P, Mukiibi J, Nakasolya O, Isooba D, Nalutaaya A, et al.
Infect Dis Poverty
. 2020 Jun;
9(1):73.
PMID: 32571435
Background: Routine tuberculosis (TB) notifications are geographically heterogeneous, but their utility in predicting the location of undiagnosed TB cases is unclear. We aimed to identify small-scale geographic areas with high...
7.
Kendall E, Kamoga C, Kitonsa P, Nalutaaya A, Salvatore P, Robsky K, et al.
PLoS One
. 2019 Jul;
14(7):e0220251.
PMID: 31339935
Background: Clinical tuberculosis diagnosis and empiric treatment have traditionally been common among patients with negative bacteriologic test results. Increasing availability of rapid molecular diagnostic tests, including Xpert MTB/RIF and the...